Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population
- PMID: 31477036
- PMCID: PMC6720417
- DOI: 10.1186/s12881-019-0884-x
Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population
Abstract
Background: Single nucleotide polymorphisms (SNPs) in several CYP genes have been associated with altered breast cancer (BC) risk in different populations. Despite this, there is a dearth of information on the roles of these SNPs in Jordanian BC patients. Therefore, this study aims to determine if there is any single nucleotide polymorphism (SNP) within CYP19A1, CYP2C19, CYP2C9, CYP1B1, CYP3A4, and CYP1A2 genes associated with BC in the Jordanian population. In addition, this work investigates the association between selected BC prognostic factors and variants of the aforementioned CYP candidate genes.
Methods: Blood samples were withdrawn from 221 BC patients and 218 healthy volunteers recruited from the Jordanian population. Genomic DNA was withdrawn and, after quantification and quality control, was genotyped using the Sequenom MassARRAY® system (iPLEX GOLD). Statistical analysis was then carried out to assess allelic and genotypic frequencies as well as genetic association between cases and controls.
Results: The CYP19A1 SNP rs7176005 (p < 0.0045) and the CYP1A2 SNP rs762551 (p = 0.004) were significantly associated with BC risk. However, no such association was found for the screened SNPs of the CYP2C9, CYP1B1, CYP2C19 and CYP3A4 genes. Regarding the prognostic factors of BC, several of the screened SNPs were associated with different pathological and clinical features.
Conclusions: Certain CYP genes, particularly CYP19A1 and CYP1A2, were associated with BC risk and development in the Jordanian population.
Keywords: Breast cancer; CYP; CYP19A1; CYP1A; Prognostic factors.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.BMC Cancer. 2016 Mar 31;16:256. doi: 10.1186/s12885-016-2284-3. BMC Cancer. 2016. PMID: 27029552 Free PMC article.
-
The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.Oncotarget. 2017 Jun 13;8(24):38367-38377. doi: 10.18632/oncotarget.16359. Oncotarget. 2017. PMID: 28418906 Free PMC article.
-
A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.PLoS One. 2017 Jan 4;12(1):e0169214. doi: 10.1371/journal.pone.0169214. eCollection 2017. PLoS One. 2017. PMID: 28052106 Free PMC article.
-
Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.BMC Med. 2015 Jun 11;13:139. doi: 10.1186/s12916-015-0373-9. BMC Med. 2015. PMID: 26067721 Free PMC article.
-
Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.Cancer Causes Control. 2015 Mar;26(3):319-32. doi: 10.1007/s10552-014-0519-7. Epub 2015 Jan 3. Cancer Causes Control. 2015. PMID: 25554091 Review.
Cited by
-
Investigating the genetic landscape of cancer in Jordan: a step toward personalized care.Eur J Med Res. 2025 Jul 2;30(1):544. doi: 10.1186/s40001-025-02799-7. Eur J Med Res. 2025. PMID: 40604932 Free PMC article. Review.
-
Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review.Biomedicines. 2024 Jul 2;12(7):1467. doi: 10.3390/biomedicines12071467. Biomedicines. 2024. PMID: 39062040 Free PMC article. Review.
-
The Association of IL-1 and HRAS Gene Polymorphisms with Breast Cancer Susceptibility in a Jordanian Population of Arab Descent: A Genotype-Phenotype Study.Cancers (Basel). 2020 Jan 23;12(2):283. doi: 10.3390/cancers12020283. Cancers (Basel). 2020. PMID: 31979384 Free PMC article.
-
The Associations of Common Genetic Susceptibility Variants with Breast Cancer in Jordanian Arabs: A Case-Control Study.Asian Pac J Cancer Prev. 2020 Oct 1;21(10):3045-3054. doi: 10.31557/APJCP.2020.21.10.3045. Asian Pac J Cancer Prev. 2020. PMID: 33112566 Free PMC article.
-
Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer.Front Pharmacol. 2020 Oct 29;11:580897. doi: 10.3389/fphar.2020.580897. eCollection 2020. Front Pharmacol. 2020. PMID: 33192522 Free PMC article. Review.
References
-
- Hrycay EG, Bandiera SM. Advances in pharmacology (San Diego, Calif.) 2015. Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer; pp. 35–84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical